A trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with outcomes improving at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, Washington residents across the state, from Seattle to Spokane and everywhere in between, have real and practical access to tirzepatide today
Once you have achieved a desired outcome, transitioning to a maintenance dose can help sustain progress
Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial
However, our medication arrived warm with a fully melted ice pack after a 17-day wait to ship, and support is limited to email from a company that carries a BBB F rating
My experience was pain free and clinically hygienic
Another possibility is that there is an association of this SNP with another disease that is highly correlated with depression